Results 91 to 100 of about 5,659,298 (338)

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload

open access: yesJournal of Global Oncology, 2017
Background To our knowledge, there is no literature that has described medical oncology (MO) workload in the global context. Here, we report results of an international study of global MO workload.
A. Fundytus   +9 more
semanticscholar   +1 more source

A Systematic Review of Evidence on the Clinical Effectiveness of Surveillance Imaging in Children With Medulloblastoma and Ependymoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Surveillance imaging aims to detect tumour relapse before symptoms develop, but it's unclear whether earlier detection of relapse leads to better outcomes in children and young people (CYP) with medulloblastoma and ependymoma. This systematic review aims to identify relevant literature to determine the efficacy of surveillance magnetic ...
Lucy Shepherd   +3 more
wiley   +1 more source

Cardio-Oncologic Knowledge of Nurses in the Oncology Service: A Multi-Center Survey in China

open access: yesJournal of Multidisciplinary Healthcare, 2023
Cuiling Zhang,1,* Ziyan Yang,2,* Rongxin Du,3 Yong Feng,4 Xiaohong Zhang,5 Junyan Zhang6 1Department of Digestive Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical ...
Zhang C   +5 more
doaj  

Focal Spot, Fall/Winter 1990 [PDF]

open access: yes, 1990
https://digitalcommons.wustl.edu/focal_spot_archives/1056/thumbnail ...

core   +1 more source

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez   +13 more
wiley   +1 more source

Chinese Expert Consensus on Clinical Application and Management of Recombinant Human Granulocyte-Colony Stimulating Factor (2026 Edition)

open access: yesZhongliu Fangzhi Yanjiu
Neutropenia is a common hematologic toxicity during antitumor therapy and can induce treatment delays, dose reduction, and even febrile neutropenia (FN), thereby causing poor prognosis.
China Anti-Cancer Association Integrated Oncologic Pharmacy Committee   +1 more
doaj   +1 more source

Focal Spot, Fall/Winter 1989 [PDF]

open access: yes, 1989
https://digitalcommons.wustl.edu/focal_spot_archives/1053/thumbnail ...

core   +1 more source

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

open access: yesClinical and Translational Oncology, 2017
This consensus statement revises and updates the recommendations for biomarkers use in the diagnosis and treatment of breast cancer, and is a joint initiative of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Ramon Colomer   +9 more
semanticscholar   +1 more source

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 (PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed.
Molly Mack   +12 more
wiley   +1 more source

Metallopanstimulin as a marker for head and neck cancer [PDF]

open access: yes, 2004
BACKGROUND: Metallopanstimulin (MPS-1) is a ribosomal protein that is found in elevated amounts in the sera of patients with head and neck squamous cell carcinoma (HNSCC).
A Agrawal   +28 more
core   +4 more sources

Home - About - Disclaimer - Privacy